Graphite Bio shares surge more than 30% above IPO price in Nasdaq debut
Graphite Bio Inc.
received a warm reception on Wall Street, as the California-based gene-editing biotechnology company's stock opened 30% above its initial public offering price. The IPO priced overnight at $17 a share, at the top of the expected range of between $15 and $17 a share, as the company raised $238 million. The stock's first trade was at $22.10 at 12:00 p.m. Eastern for about 619,000 shares. At that price, the company was valued at about $1.20 billion.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Microsoft closes with valuation above $2 trillion, becoming second U.S. company to do soMicrosoft Corp. became just the second U.S. company to close a trading day with a valuation above $2 trillion Thursday, joining Apple Inc. in an exclusive club.
Read more »
Goat Closes Series F Round of $195M, Doubles Valuation to $3.7 Billion.goatapp's new valuation doubles its previous valuation of $1.8 billion from September 2020 in nine months.
Read more »
Infrastructure and the stock market — here’s what the $1 trillion deal meansA deal on a $1 trillion infrastructure bill helped push stocks to all-time highs Thursday, here's what investors need to know.
Read more »
Er, Jennifer Aniston Said a Male Actor From ‘Friends’ Was Unpleasant on Set“It was as if they were just too ‘above’ this, to be on a sitcom.”
Read more »
Nike stock rallies as sales surpass Street estimates by more than $1 billionNike Inc. shares rose in the extended session Thursday after the company topped Wall Street revenue estimates by more than $1 billion, a far cry from the...
Read more »